Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Eur Acad Dermatol Venereol ; 30(12): 2118-2121, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27439742

ABSTRACT

BACKGROUND: Cutaneous leishmaniasis (CL) in Iran is mainly caused by Leishmania major (L. major) and L. tropica. Arginase mediated L-arginine metabolism is an important issue in Leishmania parasite propagation. Arginase activity in human CL due to L. major and L. tropica have not been studied up to now. OBJECTIVES: We aimed to compare the clinical and laboratory aspects of acute and chronic CL, focussing on arginase activity. METHODS: In this case-control study, 30 patients with acute CL (duration ≤ 1 year), 13 patients with chronic CL (duration ≥ 2 year) and 11 healthy controls were recruited. Arginase activity was measured in skin biopsies of lesions, peripheral blood polymorphonuclear cells (PMNs), peripheral blood mononuclear cells (PBMCs) and plasma by standard methods. RESULTS: The median of arginase activity in the acute lesions was higher than in chronic samples and significantly higher than in healthy controls (P = 0.008). PMNs of both acute and chronic patients showed higher levels of arginase activity as compared to the levels in PBMCs and plasma. The median of arginase activity in the PMNs of patients with chronic CL was higher than that of patients with acute CL and significantly higher than that of the healthy controls (P = 0.010). CONCLUSION: The level of arginase activity in lesions of patients with acute and chronic CL was higher than the skin of healthy controls. The highest level of arginase activity was observed in PMNs from patients with chronic CL. This suggests that the high level of arginase activity in PMNs of patients with chronic CL may contribute to the chronicity.


Subject(s)
Arginase/metabolism , Leishmania major/pathogenicity , Leishmania tropica/pathogenicity , Leishmaniasis, Cutaneous/metabolism , Acute Disease , Case-Control Studies , Chronic Disease , Humans , Leishmaniasis, Cutaneous/psychology
2.
J Bone Joint Surg Br ; 90(7): 973-9, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18591612

ABSTRACT

Curettage and packing with polymethylmethacrylate cement is a routine treatment for giant-cell tumour (GCT) of bone. We performed an in vitro evaluation of the cytotoxic effect of a combination of cement and methotrexate, doxorubicin and cisplatin on primary cell cultures of stromal GCT cells obtained from five patients. Cement cylinders containing four different concentrations of each drug were prepared, and the effect of the eluted drugs was examined at three different time intervals. We found that the cytotoxic effect of eluted drugs depended on their concentration and the time interval, with even the lowest dose of each drug demonstrating an acceptable rate of cytotoxicity. Even in low doses, cytotoxic drugs mixed with polymethylmethacrylate cement could therefore be considered as effective local adjuvant treatment for GCTs.


Subject(s)
Bone Cements/therapeutic use , Bone Neoplasms/drug therapy , Giant Cell Tumor of Bone/drug therapy , Polymethyl Methacrylate/therapeutic use , Adult , Bone Neoplasms/pathology , Chemotherapy, Adjuvant/methods , Curettage/methods , Dose-Response Relationship, Drug , Drug Delivery Systems , Female , Giant Cell Tumor of Bone/pathology , Humans , Male , Middle Aged , Neoplasm Recurrence, Local/prevention & control , Osteoblasts/drug effects , Stromal Cells/drug effects , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...